Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
Daiichi Sankyo opened a new headquarters in the Greater Toronto Area to accelerate investment and innovation in oncology, expanding its Canadian presence.
Daiichi Sankyo and GAIA join forces to commercialise digital therapeutic for high cholesterol
Daiichi Sankyo to Merge with Wholly Owned Subsidiary Daiichi Sankyo Propharma
AstraZeneca and Daiichi Sankyo Enter Global Collaboration to Jointly Develop and Commercialize Enhertu
Daiichi Sankyo has further established its presence in Canada with the official opening of its new head office in the Greater Toronto Area.
Where this signal fits in the broader landscape.
https://www.prnewswire.com/news-releases/daiichi-sankyo-unveils-new-toronto-headquarters-to-accelerate-investment-and-innovation-in-oncology-302666089.html
Read Full SourceGet curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
Sign in to save notes on signals.
Sign In